The FDA approves Bydureon - opening up the door for production and marketing of the diabetes...

|By:, SA News Editor

The FDA approves Bydureon - opening up the door for production and marketing of the diabetes shot by partners Alkermes (ALKS) and Amylin (AMLN). Shares of both firms are still halted.